SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (15190)2/17/1998 4:01:00 PM
From: Alper H.YUKSEL  Respond to of 32384
 
Henry,

How would you rate the likelihood of mediocre or poor PII results for neck and prostate trials of Targretin ?

Regards



To: Henry Niman who wrote (15190)2/17/1998 4:11:00 PM
From: WTDEC  Read Replies (1) | Respond to of 32384
 
Henry,

I agree the buy of LGNDW at $5 was super - - I hope it was yours! You certainly deserve it for all the work you put in on this thread, Links to LGND etc.

BTW, I was out of the country since late last week and only now have been able to read all the posts focused on Tamox.,Targ. and the rat tests. These were very helpful; thanks to you and the others who commented.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News